Although some recommend that medication such as selective serotonin reuptake inhibitors (SSRIs) and anxiolytics (anti-anxiety drugs) may well help address cannabis use dysfunction, proof is missing as a result of compact research sizes and different methods of assessing remedy outcomes. In te